KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Zimmer Biomet Holdings (ZBH) over the last 15 years, with Q4 2024 value amounting to $734.1 million.

  • Zimmer Biomet Holdings' Accumulated Expenses fell 864.86% to $734.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $734.1 million, marking a year-over-year decrease of 864.86%. This contributed to the annual value of $734.1 million for FY2024, which is 864.86% down from last year.
  • As of Q4 2024, Zimmer Biomet Holdings' Accumulated Expenses stood at $734.1 million, which was down 864.86% from $803.6 million recorded in Q4 2023.
  • Zimmer Biomet Holdings' 5-year Accumulated Expenses high stood at $873.1 million for Q4 2020, and its period low was $181.9 million during Q1 2020.
  • Its 5-year average for Accumulated Expenses is $437.6 million, with a median of $235.4 million in 2021.
  • As far as peak fluctuations go, Zimmer Biomet Holdings' Accumulated Expenses plummeted by 3858.66% in 2021, and later surged by 3800.45% in 2023.
  • Zimmer Biomet Holdings' Accumulated Expenses (Quarter) stood at $873.1 million in 2020, then plummeted by 38.59% to $536.2 million in 2021, then increased by 8.6% to $582.3 million in 2022, then skyrocketed by 38.0% to $803.6 million in 2023, then decreased by 8.65% to $734.1 million in 2024.
  • Its Accumulated Expenses was $734.1 million in Q4 2024, compared to $803.6 million in Q4 2023 and $234.2 million in Q1 2023.